Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N)

[Edit]

SAAS

Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N)
PCSK1Ncontains a 33-amino acid N-terminal signal sequence as well as endoprotease-processing sites. Overall sequence conservation between the human and rodent sequences is about 84%. Northern blot analysis of multiple human tissues revealed strong expression of a 1.2-kb transcript in all brain regions tested and in pancreas. Low but detectable expression was found in kidney, and no expression was found in heart, placenta, lung, liver, and skeletal muscle. Immunolocalization of rat Pcsk1n transfected into mouse pituitary corticotrophs indicated a perinuclear distribution similar to the distribution of trans-Golgi markers. Rat Pcsk1n transfected into mouse pituitary corticotrophs was secreted into the medium as a 4-kD C-terminal fragment and a 22-kD N-terminal fragment, as well as the intact 26-kD protein.

Organism species: Homo sapiens (Human)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) CLIA Kit Customized Service Offer
n/a ELISA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) ELISA Kit Customized Service Offer

Organism species: Mus musculus (Mouse)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) CLIA Kit Customized Service Offer
n/a ELISA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) ELISA Kit Customized Service Offer

Organism species: Rattus norvegicus (Rat)

CATALOG NO. PRODUCT NAME APPLICATIONS
Proteins n/a Recombinant Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Recombinant Protein Customized Service Offer
Antibodies n/a Monoclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Monoclonal Antibody Customized Service Offer
n/a Polyclonal Antibody to Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) Polyclonal Antibody Customized Service Offer
Assay Kits n/a CLIA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) CLIA Kit Customized Service Offer
n/a ELISA Kit for Proprotein Convertase Subtilisin/Kexin Type 1 Inhibitor (PCSK1N) ELISA Kit Customized Service Offer
  1. "Identification and characterization of proSAAS, a granin-like neuroendocrine peptide precursor that inhibits prohormone processing."J. Neurosci. 20:639-648(2000) [PubMed] [Europe PMC] [Abstract]
  2. "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]
  3. "Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1."J. Biol. Chem. 276:32720-32728(2001) [PubMed] [Europe PMC] [Abstract]
  4. "An N-terminal fragment of ProSAAS (a granin-like neuroendocrine peptide precursor) is associated with tau inclusions in Pick's disease."Biochem. Biophys. Res. Commun. 308:646-654(2003) [PubMed] [Europe PMC] [Abstract]
  5. "A human granin-like neuroendocrine peptide precursor (proSAAS) immunoreactivity in tau inclusions of Alzheimer's disease and parkinsonism-dementia complex on Guam."Neurosci. Lett. 356:49-52(2004) [PubMed] [Europe PMC] [Abstract]
  6. "Enrichment of glycopeptides for glycan structure and attachment site identification."Nat. Methods 6:809-811(2009) [PubMed] [Europe PMC] [Abstract]
  7. "Human urinary glycoproteomics; attachment site specific analysis of N-and O-linked glycosylations by CID and ECD."Mol. Cell. Proteomics 0:0-0(2011) [PubMed] [Europe PMC] [Abstract]
  8. "LC-MS/MS characterization of O-glycosylation sites and glycan structures of human cerebrospinal fluid glycoproteins."J. Proteome Res. 12:573-584(2013) [PubMed] [Europe PMC] [Abstract]